Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2
M. H. Miller, M. G. Shehat, J. T. Tigno-Aranjuez
This study inhibits RIP2 early in an allergic asthma model and shows reduced inflammation and Th2 skewing, but not airway hyperresponsiveness.
bioRxiv · Jun 29, 2020Immunology